Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Biosimilarity of I004 and NovoLog in Healthy Volunteers
NCT07560150Phase 3Completed
- Start
- Apr 2026
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM). Started Apr 2026; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07560150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07560150.